Literature DB >> 34240286

Association Between Neighborhood-Level Poverty and Incident Atrial Fibrillation: a Retrospective Cohort Study.

Utibe R Essien1,2, Megan E McCabe3, Kiarri N Kershaw3, Quentin R Youmans4, Michael J Fine5,6, Clyde W Yancy4, Sadiya S Khan4.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is a leading cause of cardiovascular morbidity and mortality. While neighborhood-level factors, such as poverty, have been related to prevalence of AF risk factors, the association between neighborhood poverty and incident AF has been limited.
OBJECTIVE: Using a large cohort from a health system serving the greater Chicago area, we sought to determine the association between neighborhood-level poverty and incident AF.
DESIGN: Retrospective cohort study. PARTICIPANTS: Adults, aged 30 to 80 years, without baseline cardiovascular disease from January 1, 2005, to December 31, 2018. MAIN MEASURES: We geocoded and matched residential addresses of all eligible patients to census-level poverty estimates from the American Community Survey. Neighborhood-level poverty (low, intermediate, and high) was defined as the proportion of residents in the census tract living below the federal poverty threshold. We used generalized linear mixed effects models with a logit link function to examine the association between neighborhood poverty and incident AF, adjusting for patient demographic and clinical AF risk factors. KEY
RESULTS: Among 28,858 in the cohort, patients in the high poverty group were more often non-Hispanic Black or Hispanic and had higher rates of AF risk factors. Over 5 years of follow-up, 971 (3.4%) patients developed incident AF. Of these, 502 (51.7%) were in the low poverty, 327 (33.7%) in the intermediate poverty, and 142 (14.6%) in the high poverty group. The adjusted odds ratio (aOR) of AF was higher for the intermediate poverty compared with that for the low poverty group (aOR 1.23 [95% CI 1.01-1.48]). The point estimate for the aOR of AF incidence was similar, but not statistically significant, for the high poverty compared with the low poverty group (aOR 1.25 [95% CI 0.98-1.59]).
CONCLUSION: In adults without baseline cardiovascular disease managed in a large, integrated health system, intermediate neighborhood poverty was significantly associated with incident AF. Understanding neighborhood-level drivers of AF disparities will help achieve equitable care.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Keywords:  atrial fibrillation; neighborhood; poverty; social determinants

Mesh:

Year:  2021        PMID: 34240286      PMCID: PMC9086074          DOI: 10.1007/s11606-021-06976-2

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   6.473


  38 in total

1.  Probability of stroke: a risk profile from the Framingham Study.

Authors:  P A Wolf; R B D'Agostino; A J Belanger; W B Kannel
Journal:  Stroke       Date:  1991-03       Impact factor: 7.914

2.  Association of Changes in Neighborhood-Level Racial Residential Segregation With Changes in Blood Pressure Among Black Adults: The CARDIA Study.

Authors:  Kiarri N Kershaw; Whitney R Robinson; Penny Gordon-Larsen; Margaret T Hicken; David C Goff; Mercedes R Carnethon; Catarina I Kiefe; Stephen Sidney; Ana V Diez Roux
Journal:  JAMA Intern Med       Date:  2017-07-01       Impact factor: 21.873

3.  Association of Modifiable Risk Factors in Young Adulthood With Racial Disparity in Incident Type 2 Diabetes During Middle Adulthood.

Authors:  Michael P Bancks; Kiarri Kershaw; April P Carson; Penny Gordon-Larsen; Pamela J Schreiner; Mercedes R Carnethon
Journal:  JAMA       Date:  2017-12-26       Impact factor: 56.272

4.  Socioeconomic status and the development of atrial fibrillation in Hispanics, African Americans and non-Hispanic whites.

Authors:  Eric Shulman; Faraj Kargoli; Philip Aagaard; Ethan Hoch; Luigi Di Biase; John Fisher; Jay Gross; Soo Kim; Kevin J Ferrick; Andrew Krumerman
Journal:  Clin Cardiol       Date:  2017-06-09       Impact factor: 2.882

5.  Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry.

Authors:  Harsh Golwala; Larry R Jackson; DaJuanicia N Simon; Jonathan P Piccini; Bernard Gersh; Alan S Go; Elaine M Hylek; Peter R Kowey; Kenneth W Mahaffey; Laine Thomas; Gregg C Fonarow; Eric D Peterson; Kevin L Thomas
Journal:  Am Heart J       Date:  2015-12-30       Impact factor: 4.749

6.  Incident atrial fibrillation among Asians, Hispanics, blacks, and whites.

Authors:  Thomas A Dewland; Jeffrey E Olgin; Eric Vittinghoff; Gregory M Marcus
Journal:  Circulation       Date:  2013-10-08       Impact factor: 29.690

7.  Relative contribution of modifiable risk factors for incident atrial fibrillation in Hispanics, African Americans and non-Hispanic Whites.

Authors:  Eric Shulman; Jay J Chudow; Utibe R Essien; Anusha Shanbhag; Faraj Kargoli; Jorge Romero; Luigi Di Biase; John Fisher; Andrew Krumerman; Kevin J Ferrick
Journal:  Int J Cardiol       Date:  2018-10-10       Impact factor: 4.164

8.  Socioeconomic status and the incidence of atrial fibrillation in whites and blacks: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Jeffrey R Misialek; Kathryn M Rose; Susan A Everson-Rose; Elsayed Z Soliman; Cari J Clark; Faye L Lopez; Alvaro Alonso
Journal:  J Am Heart Assoc       Date:  2014-08-20       Impact factor: 5.501

9.  Neighborhood Disorder and Obesity-Related Outcomes among Women in Chicago.

Authors:  Stephanie L Mayne; Angelina Jose; Allison Mo; Lynn Vo; Simona Rachapalli; Hussain Ali; Julia Davis; Kiarri N Kershaw
Journal:  Int J Environ Res Public Health       Date:  2018-07-03       Impact factor: 3.390

10.  Quantification of Neighborhood-Level Social Determinants of Health in the Continental United States.

Authors:  Marynia Kolak; Jay Bhatt; Yoon Hong Park; Norma A Padrón; Ayrin Molefe
Journal:  JAMA Netw Open       Date:  2020-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.